Clinical Trial Update: FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFOXIRI as primary treatment for locally advanced pancreatic cancer (Stage III) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Azienda Ospedaliero, Universitaria Pisana | Conditions: Pancreatic Carcinoma Stage III | Phase 2 | Status: COMPLETED